NAC Sub-Committees

Guideline Sub-Committee

1.0 Mandate

To provide advice and support to NAC for the CBS-Provincial/Territorial Blood Liaison Committee on the prioritization, development, dissemination, implementation and evaluation of clinical user guidelines for blood and blood products.

Key Objectives:

• Conduct an inventory of existing blood and blood product guidelines.
• Develop a process for reviewing and evaluating existing published guidelines for possible adoption and recommendation for use in Canada.
• Develop a process for determining the priority blood product guideline to be recommended to NAC for the CBS-P/T Blood Liaison Committee for development.
• Plan and host a guideline symposium in collaboration with CBS. This would also include exploring international collaboration on blood and blood product guideline development.
• Develop a framework for the development, dissemination, implementation and evaluation of NAC guidelines.
• Develop tools to support the implementation and dissemination of blood and blood product guidelines.
• Recommend policy options for the implementation of blood and blood product guidelines.

2.0 Membership

Membership will include the following:

• Dr. Anderson (Chair)
• NAC Chair
• Dr. Muirhead
• Dr. Hume
• Dr. Moltzan
• Dr. Dolan
• Dr. Nahirniak
• Dr. Alan Tinmouth – Ottawa Health Research Institute representative.

3.0 Decision Making

3.1 The working group will conduct its business by consensus.

4.0 Meetings

Meetings may be held by teleconference or in person at the call of the chair or request of a member. The NAC Secretariat will:

• Arrange teleconferences/meetings
• Record and distribute minutes of the meetings

5.0 Responsibility

The Guidelines working group is a subcommittee of NAC. The NAC is accountable to the CBS-P/T Blood Liaison Committee.

6.0 Expenses

Working group members will be reimbursed for travel expenses according to NAC guidelines.

7.0 Conflict of Interest

7.1 Any committee member that has an interest that is or could be seen by a reasonable third party to be a conflict between the committee members' professional interest and the issue that is before the committee must declare such a conflict to the committee chair. If the committee chair is in conflict of interest it must be declared to the committee. Members are to complete a conflict of interest form on an annual basis and update as appropriate for the Committee.

• National Blood Shortage
  Working Group
• Benchmarking Sub-Committee
• Safety Sub-Committee
• Guideline Sub-Committee